In particular, after a short recapitulation of background information, we will discuss the activities of CXCR4 and CXCL12 in the tumor microenvironment and the ability of CXCR4 to interact laterally with other receptors and to modulate processes that can be exploited in the context of immunotherapy. Here, CXCL12 is linked to neoplasm.